CAS: 2135696-72-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Tarlox-TKI REF: 3D-KKD69672CAS: 2135696-72-7 | Min. 95% | A consultar | Lun 13 Ene 25 |
 | Tarlox-TKI REF: TM-T11761CAS: 2135696-72-7 | 97.03% | A consultar | Mar 21 Ene 25 |
Tarlox-TKI
CAS:2135696-72-7
Tarlox-TKI is a drug with potential anti-cancer activity, which acts as a selective inhibitor of …
Fórmula:
C19H18BrClN6O
Pureza:
Min. 95%
Peso molecular:
461.7 g/mol
Ref: 3D-KKD69672
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025
Tarlox-TKI
CAS:2135696-72-7
Tarlox-TKI (Kinase inhibitor-1) is a pan-ErbB inhibitor, the active ingredient of Tarloxotinib, which has antitumor …
Fórmula:
C19H18BrClN6O
Pureza:
97.03%
Forma y color:
Solid
Peso molecular:
461.74
Ref: TM-T11761
| 1mg | 142,00 € | ||
| 1mL*10mM (DMSO) | 253,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
